Skip to main content
Equibles

ICLR · Icon PLC · Metrics

Track ICLR — free

Use ICLR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ICLR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$161.85 -8.14 (-4.79%) At close · Oct 1
Rebalance outlook locked
Market Cap
$13.30B
Shares
77.15M
Volume · Oct 1 677.23K Avg daily vol (3M) 809.54K

ICLR metrics

76 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$161.85
Market cap
$13.30B

Price action

20 metrics
Price change (1W)
+3.7%
Price change (30D)
+5.3%
Price change (3M)
-2.9%
Price change (6M)
+52.6%
Price change (YTD)
-6.7%
Price change (1Y)
-2.9%
Trailing year
Price change (5Y)
-35.1%
52-week high
$202.92
52-week low
$80.08
Change from 52-week high
-16.2%
Change from 52-week low
+112.3%
Annualized volatility
67.2%
Annualized volatility (3M)
38.4%
Beta
1.3
RSI (14D)
51.7
Price vs SMA 50
+1.4%
Price vs SMA 200
+15.9%
Avg volume (3M)
811,601
Relative volume
1.1
Average dollar volume
$136.64M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
77.15M

Valuation

12 metrics
P / E (TTM)
261.5
Trailing earnings · reciprocal yield 0.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 62.4%
P / book
1.4
reciprocal yield 70.5%
FCF yield
6.6%
TTM · current market cap
Buyback yield
1.9%
P / FCF
15.0
reciprocal yield 6.6%
P / operating cash flow
12.4
reciprocal yield 8.0%
Earnings yield
0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
51.4×
reciprocal yield 1.9%
P / E historical average (5Y)
54.0×
reciprocal yield 1.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
3.6%
Trailing 12 months
Net margin
0.5%
Gross profit (TTM)
—
Operating profit (TTM)
$296.50M
Net income (TTM)
$42.34M
Trailing 12 months
Diluted EPS (TTM)
$0.65
FCF margin
10.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$121.55

Growth

11 metrics
Revenue growth YoY
+1.2%
Year over year
Net income growth YoY
-64.3%
Revenue (TTM)
$8.29B
Trailing 12 months
EPS growth YoY
-63.3%
Shares change YoY
-2.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+24.2%
EPS CAGR (3Y)
-22.1%
EPS CAGR (5Y)
-14.0%
FCF CAGR (3Y)
+27.0%
FCF CAGR (5Y)
+10.3%

Quality

14 metrics
Return on equity
0.5%
Return on assets
0.3%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$666.92M
Free cash flow (TTM)
$883.82M
Quick ratio
—
Interest coverage
1.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$928.38M
Total assets
$16.40B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.07B
Capital expenditures (TTM)
$186.22M
R&D (TTM)
—
SG&A (TTM)
$771.66M
Stock compensation (TTM)
$120.46M
R&D / revenue
—
Stock compensation / revenue
1.5%

Ownership (13F)

3 metrics
13F filers
429
13F filer change QoQ
+6
Institutional ownership
105.5%

Short interest

3 metrics
Short interest
3.4%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.04M
Insider-sentiment score
16 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1060955 CUSIP G4705A100 13F (30d) 15 filings 7 filers Visit website Investor relations